Enhancing corporate value through an employee stock ownership plan
First written in FY2016. 2 of 27 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2026.
21 other companies' latest entry also says "Other".
- FY2026Holding balance updateAnnual report
「Shares held in the holder's own name (shares): 787,800; shares held in other names (shares): 197,400; total shares held (shares): 985,200; ratio of shares held to total shares issued (%): 8.4.」
The balance of shares held, including the Employee Stock Benefit Trust, was updated to a total of 985,200 shares, or 8.4% of total shares issued. - FY2026-H1Holding balance updateAnnual report
「Shares held in the holder's own name (shares): 787,700; shares held in other names (shares): 204,000; total shares held (shares): 991,700; ratio of shares held to total shares issued (%): 8.5.」
The balance of shares held, including shares held under the Employee Stock Benefit Trust, was updated to a total of 991,700 shares, or 8.5% of total shares issued. - FY2025Holding balance updateAnnual report
「Shares held in the holder's own name (shares): 795,100; shares held in other names (shares): 206,100; total shares held (shares): 1,001,200; ratio of shares held to total shares issued (%): 8.5.」
The balance of shares held, including shares held under the Employee Stock Benefit Trust, was updated to a total of 1,001,200 shares, or 8.5% of total shares issued. - FY2025-H1Holding balance updateAnnual report
「株式会社中京医薬品 Shares held in the holder's own name (shares): 794,900; shares held in other names (shares): 208,600; total shares held (shares): 1,003,500; ratio of shares held to total shares issued (%): 8.6.」
The balance of shares held, including shares held under the Employee Stock Benefit Trust, was updated to a total of 1,003,500 shares, or 8.6% of total shares issued. - FY2024Holding balance updateAnnual report
「株式会社中京医薬品 Shares held in the holder's own name (shares): 802,100; shares held in other names (shares): 211,300; total shares held (shares): 1,013,400; ratio of shares held to total shares issued (%): 8.6.」
Shares held, including shares held under the Employee Stock Benefit Trust, totaled 1,013,400 shares, or 8.6% of total shares issued. - FY2024-Q3Holding balance updateAnnual report
「Shares held in the holder's own name (shares): 802,000; shares held in other names (shares): 214,700; total shares held (shares): 1,016,700; ratio of shares held to total shares issued (%): 8.7.」
The balance of shares held, including shares held under the Employee Stock Benefit Trust, was updated to a total of 1,016,700 shares, or 8.7% of total shares issued. - FY2024-Q2Holding balance updateAnnual report
「Shares held in the holder's own name (shares): 802,000; shares held in other names (shares): 214,700; total shares held (shares): 1,016,700; ratio of shares held to total shares issued (%): 8.7.」
The balance of shares held, including shares held under the Employee Stock Benefit Trust, was updated to a total of 1,016,700 shares, or 8.7% of total shares issued. - FY2023Holding balance updateAnnual report
「Shares held in the holder's own name (shares): 808,800; shares held in other names (shares): 215,900; total shares held (shares): 1,024,700; ratio of shares held to total shares issued (%): 8.7.」
The balance of shares held, including the Employee Stock Benefit Trust, was updated to a total of 1,024,700 shares, or 8.7% of total shares issued. - FY2023-Q2Holding balance updateAnnual report
「株式会社中京医薬品 Shares held in the holder's own name (shares): 808,500; shares held in other names (shares): 217,100; total shares held (shares): 1,025,600; ratio of shares held to total shares issued (%): 8.7.」
The balance of shares held, including shares held under the Employee Stock Benefit Trust, was updated to a total of 1,025,600 shares, or 8.7% of total shares issued. - FY2022Holding balance updateAnnual report
「Shares held in the holder's own name (shares): 814,100; shares held in other names (shares): 218,500; total shares held (shares): 1,032,600; ratio of shares held to total shares issued (%): 8.8.」
Shares held, including shares held under the Employee Stock Benefit Trust, totaled 1,032,600 shares, or 8.8% of total shares issued. - FY2022-Q2Holding balance updateAnnual report
「株式会社中京医薬品 Shares held in the holder's own name (shares): 814,000; shares held in other names (shares): 219,200; total shares held (shares): 1,033,200; ratio of shares held to total shares issued (%): 8.8.」
The balance of shares held, including shares held under the Employee Stock Benefit Trust, was updated to a total of 1,033,200 shares, or 8.8% of total shares issued. - FY2021Holding balance updateAnnual report
「Shares held in the holder's own name: 1,300,700 shares; shares held in other names: 269,300 shares; total shares held: 1,570,000 shares; ratio of shares held to total shares issued: 13.4%.」
Shares held, including trust assets for the Employee Stock Benefit program and other programs, total 1,570,000 shares, or 13.4% of total shares issued. The balance declined from the previous year's total of 3,039,200 shares, or 26.0%. - FY2021-Q3Holding balance updateAnnual report
「Shares held in the holder's own name: 2,755,300 shares; shares held in other names: 283,900 shares; total shares held: 3,039,200 shares; ratio of shares held to total shares issued: 26.0%. Contributed as trust assets for the "Stock Benefit Trust (J-ESOP)" program. Contributed as trust assets for the "Employee Stock Benefit" program.」
The balance of shares held, including trust assets for the Employee Stock Benefit program and other programs, was updated to a total of 3,039,200 shares, or 26.0% of total shares issued. - FY2021-Q2Holding balance updateAnnual report
「Shares held in the holder's own name: 2,755,300 shares; shares held in other names: 283,900 shares; total shares held: 3,039,200 shares; ratio of shares held to total shares issued: 26.0%. Contributed as trust assets for the "Stock Benefit Trust (J-ESOP)" program. Contributed as trust assets for the "Employee Stock Benefit" program.」
The balance of shares held, including trust assets for the Employee Stock Benefit program and other programs, was updated to a total of 3,039,200 shares, or 26.0% of total shares issued. - FY2020Holding balance updateAnnual report
「Shares held in the holder's own name: 2,921,500 shares; shares held in other names: 297,200 shares; total shares held: 3,218,700 shares; ratio of shares held to total shares issued: 27.6%.」
The balance of shares held, including trust assets for the Employee Stock Benefit program and other programs, was updated to a total of 3,218,700 shares, or 27.6% of total shares issued. - FY2020-Q3Holding balance updateAnnual report
「Shares held in the holder's own name: 2,920,800 shares; shares held in other names: 318,800 shares; total shares held: 3,239,600 shares; ratio of shares held to total shares issued: 27.7%. Contributed as trust assets for the "Stock Benefit Trust (J-ESOP)" program. Contributed as trust assets for the "Employee Stock Benefit" program.」
The balance of shares held, including trust assets for the Employee Stock Benefit program and other programs, was updated to a total of 3,239,600 shares, or 27.7% of total shares issued. - FY2019Holding balance updateAnnual report
「Shares held in the holder's own name: 2,920,600 shares; shares held in other names: 343,700 shares; total shares held: 3,264,300 shares; ratio of shares held to total shares issued: 27.9%.」
The balance of treasury shares and other shares held, including trust assets for the Employee Stock Benefit program and other programs, was updated to a total of 3,264,300 shares, or 27.9% of total shares issued. - FY2019-Q3Holding balance updateAnnual report
「Shares held in the holder's own name: 2,920,500 shares; shares held in other names: 367,300 shares; total shares held: 3,287,800 shares; ratio of shares held to total shares issued: 28.2%. Contributed as trust assets for the "Stock Benefit Trust (J-ESOP)" program. Contributed as trust assets for the "Employee Stock Benefit" program.」
The balance of shares held, including trust assets for the Employee Stock Benefit program and other programs, was updated to a total of 3,287,800 shares, or 28.2% of total shares issued. - FY2019-Q2Holding balance updateAnnual report
「Shares held in the holder's own name: 2,920,500 shares; shares held in other names: 367,300 shares; total shares held: 3,287,800 shares; ratio of shares held to total shares issued: 28.2%. Contributed as trust assets for the "Stock Benefit Trust (J-ESOP)" program. Contributed as trust assets for the "Employee Stock Benefit" program.」
The balance of shares held, including trust assets for the Employee Stock Benefit program and other programs, was updated to a total of 3,287,800 shares, or 28.2% of total shares issued. - FY2018Holding balance updateAnnual report
「Shares held in the holder's own name: 2,920,400 shares; shares held in other names: 391,600 shares; total shares held: 3,312,000 shares; ratio of shares held to total shares issued: 28.4%. Contributed as trust assets for the "Stock Benefit Trust (J-ESOP)" program. Contributed as trust assets for the "Employee Stock Benefit" program.」
Shares held, including trust assets for the Employee Stock Benefit program and other programs, totaled 3,312,000 shares, or 28.4% of total shares issued. - FY2018-Q2Holding balance updateAnnual report
「Shares held in the holder's own name: 2,920,400 shares; shares held in other names: 416,000 shares; total shares held: 3,336,400 shares; ratio of shares held to total shares issued: 28.6%. Contributed as trust assets for the "Stock Benefit Trust (J-ESOP)" program. Contributed as trust assets for the "Employee Stock Benefit" program.」
Shares held, including those contributed to the Employee Stock Benefit program and other programs, total 3,336,400 shares, or 28.6% of total shares issued. - FY2018-Q1Holding balance updateAnnual report
「Shares held in the holder's own name: 2,920,400 shares; shares held in other names: 441,000 shares; total shares held: 3,361,400 shares; ratio of shares held to total shares issued: 28.8%. Contributed as trust assets for the "Stock Benefit Trust (J-ESOP)" program. Contributed as trust assets for the "Employee Stock Benefit" program.」
Shares held, including those contributed to the Employee Stock Benefit program and other programs, total 3,361,400 shares, or 28.8% of total shares issued. - FY2017AdvancedAnnual report
「As a measure to further enhance employee morale and improve employee welfare, the Company reintroduced the employee incentive ESOP by resolution of a Board of Directors meeting held on 10 August 2016. Total number of shares planned to be acquired for the employee stock ownership association: 240,000 shares. Trust period: 19 August 2016 to 31 August 2021.」
The Company reintroduced the employee incentive ESOP and disclosed details of the scheme, including the trust period and the planned acquisition of 240,000 shares. - FY2017-Q3Holding balance updateAnnual report
「Number of shares held in the Company's own name: 2,864,400; number of shares held in another person's name: 466,400; total shares held: 3,330,800; ratio of shares held to total shares issued: 28.5%. Contributed as trust assets for the J-ESOP stock benefit trust; contributed as trust assets for the employee stock benefit plan.」
The Company continues to contribute shares to the employee stock benefit plan, and shares held, including those held in trust, total 3,330,800, representing 28.5% of total shares issued. - FY2017-Q2RestatedAnnual report
「Contributed as trust assets for the J-ESOP stock benefit trust; contributed as trust assets for the employee stock benefit plan.」
The Company continues to disclose contributions of shares to the employee stock ownership trust and the employee stock benefit trust. - FY2017-Q1AdvancedAnnual report
「Number of shares held in the Company's own name: 2,945,300; number of shares held in another person's name: 405,300; total shares held: 3,350,600; ratio of shares held to total shares issued: 28.7%. Reason for holding: contributed as trust assets for the J-ESOP stock benefit trust and as trust assets for the employee stock benefit plan.」
The disclosure states that shares have actually been contributed as trust assets for the employee stock benefit plan. - FY2016First statedAnnual report
「The Company aims to enhance corporate value by strengthening corporate governance, including by fostering employees' awareness of participating in corporate management through the Company's shares.」
In addition to the employee stock ownership ESOP, the Company resolved to introduce an employee stock benefit trust in February 2016.